Press releases

Month Year

Email alerts

Sep 3, 2013

Medtronic Presents Final Three-Year Data From Symplicity HTN-1 Showing Significant and Sustained Drops in Blood Pressure After Treatment with the Symplicity(TM) Renal Denervation System

Thomson Reuters ONE via COMTEX) --Final Clinical Outcomes from First and Longest-Running Renal Denervation Clinical Study Presented During European Society of Cardiology Congress and Accepted for...
Sep 2, 2013

Medtronic Announces Formation of Hospital Solutions Business Aimed at Driving Efficiencies and Cost Savings

Thomson Reuters ONE via COMTEX) --Medtronic Hospital Solutions Signs First Contracts with Two Leading Hospitals in Europe and Makes Equity Investment in NGC Medical MINNEAPOLIS AND TOLOCHENAZ -...
Sep 2, 2013

Medtronic Reports Strong Safety and Sustained Clinical Efficacy Results of the Symplicity(TM) Renal Denervation System from the Global SYMPLICITY Registry

(Thomson Reuters ONE via COMTEX) --Six and 12-Month Data from Largest Real-World Patient Population Consistent with Symplicity Randomized Clinical Trial MINNEAPOLIS and AMSTERDAM - September 2,...
Aug 29, 2013

Medtronic To Set Up Global Center Of Excellence In Singapore For Business Model Innovation

Thomson Reuters ONE via COMTEX) --MINNEAPOLIS and SINGAPORE, Aug. 29, 2013 - Medtronic announced today the official opening of a global Center of Excellence (CoE) for Business Model Innovation in...
Aug 22, 2013

Medtronic Announces Cash Dividend for Second Quarter of Fiscal Year 2014

Thomson Reuters ONE via COMTEX) --MINNEAPOLIS - August 22, 2013 - The board of directors of Medtronic, Inc. (NYSE:MDT) today approved a cash dividend of $0.28 per share of the company's common...

Show per page